1. Home
  2. MDBH vs CCEL Comparison

MDBH vs CCEL Comparison

Compare MDBH & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MDB Capital Holdings LLC common

MDBH

MDB Capital Holdings LLC common

HOLD

Current Price

$3.63

Market Cap

36.7M

Sector

N/A

ML Signal

HOLD

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$3.56

Market Cap

32.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDBH
CCEL
Founded
1997
1989
Country
United States
United States
Employees
40
N/A
Industry
Managed Health Care
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.7M
32.7M
IPO Year
2023
1997

Fundamental Metrics

Financial Performance
Metric
MDBH
CCEL
Price
$3.63
$3.56
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
14.7K
11.8K
Earning Date
11-13-2025
02-27-2026
Dividend Yield
N/A
11.30%
EPS Growth
N/A
N/A
EPS
0.76
N/A
Revenue
$1,250,398.00
$31,747,500.00
Revenue This Year
N/A
$0.30
Revenue Next Year
N/A
N/A
P/E Ratio
$4.75
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.11
$3.19
52 Week High
$7.98
$8.79

Technical Indicators

Market Signals
Indicator
MDBH
CCEL
Relative Strength Index (RSI) 53.11 41.77
Support Level $3.11 $3.49
Resistance Level $3.69 $4.14
Average True Range (ATR) 0.19 0.29
MACD 0.03 0.01
Stochastic Oscillator 70.69 35.78

Price Performance

Historical Comparison
MDBH
CCEL

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: